Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes

Biologic TNFα inhibitors are a mainstay treatment option for patients with rheumatoid arthritis (RA) refractory to other treatment options. However, many patients either do not respond or relapse after initially responding to these agents. This study was carried out to identify biomarkers that can d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bystrom, Jonas, Clanchy, Felix I., Taher, Taher E., Al-Bogami, Mohammed M., Muhammad, Hawzheen A., Alzabin, Saba, Mangat, Pamela, Jawad, Ali S., Williams, Richard O., Mageed, Rizgar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597702/
https://www.ncbi.nlm.nih.gov/pubmed/28488248
http://dx.doi.org/10.1007/s12016-017-8610-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597702/
https://www.ncbi.nlm.nih.gov/pubmed/28488248
http://dx.doi.org/10.1007/s12016-017-8610-y

Ejemplares similares